Miller VA - Search Results

1

The Clinical Use of Genomic Profiling to Distinguish Intrapulmonary Metastases From Synchronous Primaries in Non-Small-Cell Lung Cancer: A Mini-Review.

Klempner SJ, Ou SH, Costa DB, VanderLaan PA, Sanford EM, Schrock A, Gay L, Ali SM, Miller VA. Klempner SJ, et al. Among authors: miller va. Clin Lung Cancer. 2015 Sep;16(5):334-339.e1. doi: 10.1016/j.cllc.2015.03.004. Epub 2015 Mar 26. Clin Lung Cancer. 2015. PMID: 25911330 Review.

2

Trastuzumab in the treatment of non-small cell lung cancer.

Azzoli CG, Krug LM, Miller VA, Kris MG, Mass R. Azzoli CG, et al. Among authors: miller va. Semin Oncol. 2002 Feb;29(1 Suppl 4):59-65. doi: 10.1053/sonc.2002.31526. Semin Oncol. 2002. PMID: 11894015 Review.

3

The clinical course of nonsmall cell lung carcinoma in survivors of Hodgkin disease.

Laurie SA, Kris MG, Portlock CS, Rosenzweig KE, Miller VA, Krug LM, Rusch VW. Laurie SA, et al. Among authors: miller va. Cancer. 2002 Jul 1;95(1):119-26. doi: 10.1002/cncr.10628. Cancer. 2002. PMID: 12115325 Free article.

4

A phase II trial of chemotherapy and surgery for non-small cell lung cancer patients with a synchronous solitary metastasis.

Downey RJ, Ng KK, Kris MG, Bains MS, Miller VA, Heelan R, Bilsky M, Ginsberg R, Rusch VW. Downey RJ, et al. Among authors: miller va. Lung Cancer. 2002 Nov;38(2):193-7. doi: 10.1016/s0169-5002(02)00183-6. Lung Cancer. 2002. PMID: 12399132 Clinical Trial.

5

Bcl-2 and bax expression in advanced non-small cell lung cancer: lack of correlation with chemotherapy response or survival in patients treated with docetaxel plus vinorelbine.

Krug LM, Miller VA, Filippa DA, Venkatraman E, Ng KK, Kris MG. Krug LM, et al. Among authors: miller va. Lung Cancer. 2003 Feb;39(2):139-43. doi: 10.1016/s0169-5002(02)00443-9. Lung Cancer. 2003. PMID: 12581565 Clinical Trial.

6

Antitumor activity and tolerability of gefitinib in patients with non-small-cell lung cancer treated in an expanded access program.

Shah NT, Miller VA. Shah NT, et al. Among authors: miller va. Clin Lung Cancer. 2003 Nov;5(3):182-6. doi: 10.3816/CLC.2003.n.032. Clin Lung Cancer. 2003. PMID: 14667275

7

Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib.

Riely GJ, Pao W, Pham D, Li AR, Rizvi N, Venkatraman ES, Zakowski MF, Kris MG, Ladanyi M, Miller VA. Riely GJ, et al. Among authors: miller va. Clin Cancer Res. 2006 Feb 1;12(3 Pt 1):839-44. doi: 10.1158/1078-0432.CCR-05-1846. Clin Cancer Res. 2006. PMID: 16467097 Clinical Trial.

8

Update on epidermal growth factor receptor mutations in non-small cell lung cancer.

Riely GJ, Politi KA, Miller VA, Pao W. Riely GJ, et al. Among authors: miller va. Clin Cancer Res. 2006 Dec 15;12(24):7232-41. doi: 10.1158/1078-0432.CCR-06-0658. Clin Cancer Res. 2006. PMID: 17189394 Review.

9

Vascular endothelial growth factor trap in non small cell lung cancer.

Riely GJ, Miller VA. Riely GJ, et al. Among authors: miller va. Clin Cancer Res. 2007 Aug 1;13(15 Pt 2):s4623-7. doi: 10.1158/1078-0432.CCR-07-0544. Clin Cancer Res. 2007. PMID: 17671153 Review.

10

Impact of epidermal growth factor receptor and KRAS mutations on clinical outcomes in previously untreated non-small cell lung cancer patients: results of an online tumor registry of clinical trials.

Jackman DM, Miller VA, Cioffredi LA, Yeap BY, Jänne PA, Riely GJ, Ruiz MG, Giaccone G, Sequist LV, Johnson BE. Jackman DM, et al. Among authors: miller va. Clin Cancer Res. 2009 Aug 15;15(16):5267-73. doi: 10.1158/1078-0432.CCR-09-0888. Epub 2009 Aug 11. Clin Cancer Res. 2009. PMID: 19671843 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

485 results

Search Page

Filters